Skip to main content


Fig. 4 | BMC Nephrology

Fig. 4

From: Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy

Fig. 4

Proteinuria levels, serum albumin levels, eGFR levels, blood pressure and the TAC doses in three groups. a shows that the decrease in proteinuria was significantly greater in the TAC + TMG group compared with the other two groups in the 6th, 8th, and 10th months b shows that serum albumin increased in all three groups after treatment (P < 0.001). c to e respectively showed that there were no significant differences in eGFR, systolic blood pressure, and diastolic blood pressure among the three groups after treatment (P > 0.05). The TAC doses of the three groups are shown in (f)

Back to article page